A newly established company called Grail and spun out from Illumina promises to develop a “liquid biopsy” test suitable for asymptomatic cancer detection and general screening. While the necessary sensitivity may be ...

A Genome Wide Association Study on propensity to motion sickness published by 23andMe gives interesting results, shows validity for self-reported phenotypic information and underlines the value of the model developed by ...

An extension of newborn screening to genome sequencing is now feasible but raises a number of scientific, organisational and ethical issues. This is being explored in discussions and in several funded trials, in order to ...

Sequencing technology now makes possible non-invasive prenatal diagnosis, and may soon allow detailed examination of the embryo genome from analysis of a single cell. These positive developments that avoid potentially ...

Direct-to-consumer (DTC) genetic tests have become quite popular in the USA. This article explores the uses to which they are put and the motivations of the customers.